JUPITER MEDICAL CENTER ANNOUNCES CLINICAL STUDY FOR PREVENTING COLON CANCER RE-OCCURRENCE

February 13, 2012

JUPITER MEDICAL CENTER ANNOUNCES CLINICAL STUDY FOR PREVENTING

COLON CANCER RE-OCCURRENCE

 

February 13, 2012 – Jupiter, FL -Patients who have had colon cancer have a greater than average risk of developing polyps in the colon and rectum. These polyps could become colon cancer in the future. The purpose of the NSABP P-5 study is to find out if the drug Rosuvastatin, also called Crestor®, will prevent the occurrence of polyps in the colon or rectum, and prevent development of new colon cancer.

 

The NSABP is an international cancer research organization supported by the National Cancer Institute (NCI). The NSABP has more than 50 years of experience in conducting research studies designed to improve the survival and the quality of life of patients with breast or bowel cancer.

 

Participants will include men and women who:

• Have had a Stage I or II colon cancer surgically removed within the last 12 months

• Are not currently being treated for high cholesterol or are not on any cholesterol-lowering medications

• Have had a colonoscopy within the last 6 months or are willing to have one at study entry

Patients will be assigned by chance or randomized to one of two groups. One group will receive Rosuvastatin (Crestor®) and the other group will receive a placebo. Both groups will take one pill a day for 5 years. The pills will be supplied free of charge by the study.

 

Jupiter Medical Center Clinical Research professionals will closely monitor all patients through regularly scheduled visits during the study. In addition, several Jupiter Medical Center gastrointestinal doctors, including Sheldon Taub, MD, Board Certified, Gastroenterologist; Roger Koerner, MD, Board Certified, Gastroenterologist; Jefferson Vaughan, MD, Board Certified, General Surgeon and Ronald Zelnick, MD, Board Certified, General Surgeon & Colon Rectal Surgeon, will be assisting in the screening of patients for this study.

 

For more information on participating in clinical trials at Jupiter Medical Center, please contact Jeanine Secor, RN, BSN, Manager of Clinical Research, at 561-263-5791, Estelle Hansen, RN, BSN, Clinical Research Nurse, at 561-263-5768, or visit our website www.jupitermed.com

 

–The Jupiter Medical Center Clinical Research Department and National Surgical Adjuvant Breast and Bowel Project (NSABP) are pleased to offer patients access to a large-scale national colon cancer prevention study called NSABP P-5. Men and women who have a history of colon cancer may be eligible to enter this study. The goal of the study is to prevent colon cancer re-occurrence.
 

About Jupiter Medical Center

A not-for-profit 283-bed community Medical Center consisting of 163 private acute care hospital beds and 120 long-term care, sub-acute rehabilitation and Hospice beds, Jupiter Medical Center provides a broad range of services with specialty concentrations in orthopedics and spine, geriatrics, minimally invasive surgical procedures including robotic surgery, emergency services, cardiac services, obstetrics, cancer care and advanced diagnostics. Founded in 1979, Jupiter Medical Center is the highest ranked hospital in Palm Beach County by U.S. News & World Report, and was recognized as "high performing" in five specialty areas, including cancer, ear, nose and throat, gynecology, kidney disorders, and neurology and neurosurgery. The Medical Center has approximately 1,500 team members, 520 physicians and 700 volunteers.

# # # 

Press ReleasesPR 2012